New hope for brittle diabetes? trial combines experimental drug and cell transplant
NCT ID NCT07592000
First seen May 19, 2026 · Last updated May 19, 2026
Summary
This early-phase study tests whether a new drug called tegoprubart, along with other medications, can safely help islet cell transplants work better in people with type 1 diabetes and chronic kidney disease. About 10 adults will receive the transplant and take immunosuppressants for life. The goal is to improve blood sugar control and reduce dangerous low blood sugar episodes, but this is not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
The University of Chicago
RECRUITINGChicago, Illinois, 60637, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.